BofA/Merrill Lynch Starts Abbvie (ABBV) at Buy
Tweet
Share
E-mailGet Alerts ABBV Hot Sheet
Price: $250.09 +0.85%
Rating Summary:
27 Buy, 11 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 23 | New: 12
Rating Summary:
27 Buy, 11 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 23 | New: 12
Join SI Premium – FREE
BofA/Merrill Lynch initiates coverage on Abbvie (NYSE: ABBV) with a Buy. PT $40.00.
For an analyst ratings summary and ratings history on Abbvie click here. For more ratings news on Abbvie click here.
Shares of Abbvie closed at $34.83 yesterday.
For an analyst ratings summary and ratings history on Abbvie click here. For more ratings news on Abbvie click here.
Shares of Abbvie closed at $34.83 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Craig-Hallum Starts Alterity Therapeutics (ATHE) at Buy
- Ferguson prices $1.2 billion in senior unsecured notes offering
- Blue Owl Capital plans 10-year senior notes to repay credit facility
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
